Notably, SD3 was enriched in the negative regulation of RIG‐I signalling with high expression of BTNL9 and TXNIP, indicating endogenous anti‐immune activation and an anti‐antigen presentation module in sarcoma (Figure 5C,D). The gene discussed is BTNL9; the disease is sarcoma.